AIMS: To report our experience of neonatal screening for sickle cell disease in Ouagadougou (Burkina Faso) and to discuss the feasibility of neonatal screening in this country. METHODS: Between the years 2000 and 2004, there were about 2,341 births in five maternity services in Ouagadougou. These babies were screened for sickle cell disease in a universal screening pilot programme. In 2006, 53 babies born to selected couples were screened. The specimens were collected either by cord blood sampling or from a dried blood spot on filter paper. The screening was performed using an isoelectric focusing technique. RESULTS: In the first stage (2000-4), the incidence of sickle cell disease was 1:57. In the second stage, six of 53 babies of selected couples were found to have major haemoglobinopathies: one was homozygous for haemoglobin S and five were compound heterozygotes for haemoglobins S and C. CONCLUSIONS: The results suggest that a national screening programme should be implemented in Burkina Faso with effective newborn and subsequent follow-up, but a methodology needs to be developed.
AIMS: To report our experience of neonatal screening for sickle cell disease in Ouagadougou (Burkina Faso) and to discuss the feasibility of neonatal screening in this country. METHODS: Between the years 2000 and 2004, there were about 2,341 births in five maternity services in Ouagadougou. These babies were screened for sickle cell disease in a universal screening pilot programme. In 2006, 53 babies born to selected couples were screened. The specimens were collected either by cord blood sampling or from a dried blood spot on filter paper. The screening was performed using an isoelectric focusing technique. RESULTS: In the first stage (2000-4), the incidence of sickle cell disease was 1:57. In the second stage, six of 53 babies of selected couples were found to have major haemoglobinopathies: one was homozygous for haemoglobin S and five were compound heterozygotes for haemoglobins S and C. CONCLUSIONS: The results suggest that a national screening programme should be implemented in Burkina Faso with effective newborn and subsequent follow-up, but a methodology needs to be developed.
Authors: Charlotte F McAuley; Clare Webb; Julie Makani; Alexander Macharia; Sophie Uyoga; Daniel H Opi; Carolyne Ndila; Antony Ngatia; John Anthony G Scott; Kevin Marsh; Thomas N Williams Journal: Blood Date: 2010-06-08 Impact factor: 22.113
Authors: Kofi A Anie; Marsha J Treadwell; Althea M Grant; Jemima A Dennis-Antwi; Mabel K Asafo; Mary E Lamptey; Jelili Ojodu; Careema Yusuf; Ayo Otaigbe; Kwaku Ohene-Frempong Journal: J Community Genet Date: 2016-04-18
Authors: Beverly A Schaefer; Charles Kiyaga; Thad A Howard; Grace Ndeezi; Arielle G Hernandez; Isaac Ssewanyana; Mary C Paniagua; Christopher M Ndugwa; Jane R Aceng; Russell E Ware Journal: Blood Adv Date: 2016-11-22
Authors: Bradford L Therrell; Michele A Lloyd-Puryear; Kwaku Ohene-Frempong; Russell E Ware; Carmencita D Padilla; Emmanuela E Ambrose; Amina Barkat; Hassan Ghazal; Charles Kiyaga; Tisungane Mvalo; Obiageli Nnodu; Karim Ouldim; Mohamed Chérif Rahimy; Brígida Santos; Léon Tshilolo; Careema Yusuf; Guisou Zarbalian; Michael S Watson Journal: J Community Genet Date: 2020-05-15
Authors: Claudia Frömmel; Annemarie Brose; Jeannette Klein; Oliver Blankenstein; Stephan Lobitz Journal: Biomed Res Int Date: 2014-07-23 Impact factor: 3.411
Authors: Alex W Macharia; George Mochamah; Sophie Uyoga; Carolyne M Ndila; Gideon Nyutu; Johnstone Makale; Metrine Tendwa; Emily Nyatichi; John Ojal; Mohammed Shebe; Kennedy O Awuondo; Neema Mturi; Norbert Peshu; Benjamin Tsofa; J Anthony G Scott; Kathryn Maitland; Thomas N Williams Journal: Am J Hematol Date: 2017-12-18 Impact factor: 10.047
Authors: Lewis Hsu; Obiageli E Nnodu; Biobele J Brown; Furahini Tluway; Shonda King; Livingstone G Dogara; Crystal Patil; Sergey S Shevkoplyas; Guillaume Lettre; Richard S Cooper; Victor R Gordeuk; Bamidele O Tayo Journal: J Trop Dis Public Health Date: 2018-07-10